Swiss privacy-focused company Threema has transferred ownership to the Germany-based firm Comitis Capital GmbH. Since 2020, the company had been under the leadership of private equity firm Afinum ...
DistalMotion, the Lausanne-based company empowering access to robotic surgery in outpatient sites of care, has secured a strategic investment from Johnson & Johnson, through its corporate venture ...
Following a review by the Issuer Committee of SIX Swiss Exchange, Management and the Board of Directors have decided to pause Future Holdings AG’s current project in its existing structure. The ...
Das CleanTech-Startup Oxoia hat über ein Convertible Loan Agreement (CLA) eine Million Franken eingesammelt. Mit seiner KI-gestützten Software zur Minimierung des Energieverbrauchs in Gebäuden konnte ...
To change this, Spacetek, founded in 2018 as a spin-off from the University of Bern, has developed a time-of-flight mass spectrometry (TOF-MS) system for use in semiconductor manufacturing. The device ...
Das Zuger Start-up Delos Analytica hat seine KI-gestützte Intelligence Platform Delos offiziell lanciert. Sie vereint Issue- und Stakeholderbeobachtung, politisches und mediales Monitoring sowie ...
Oculis, Legacy Healthcare and Neurosterix are advancing their drug pipelines with major clinical milestones. Oculis’ Privosegtor received breakthrough therapy designation from the U.S. Food and Drug ...
In der drei Startups aus dem Kanton Zürich stehen Managementwechsel an. UNISERS ernennt einen neuen CEO, Ason Payroll Engine besetzt die Geschäftsleitung mit einem erfahrenen Serial-Gründer und ...
Das St. Moritzer Startup Bee People hat vor wenigen Monaten den Vertrieb seiner Nahrungsergänzungskapseln und Bio-Propolis- ...
The project will deploy Techponics ’ automated system designed to optimize crop density, resource utilization, and production flow from transplant to harvest. This proprietary spacing technology - a ...
The Fribourg-based sportswear startup Revario has just hit CHF 1 million in sales. This achievement is even more remarkable given that the company, founded by Michael Ingram, has so far sold its ...
Windward Bio, a clinical-stage biotechnology company, launched in early 2025 with a $200M Series A led by top-tier investors. The company is building a pipeline of long-acting bispecific antibodies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback